Survival of the Fittest


Ed Wachenheim of Greenhaven Associates explains why he doesn't mind boring his fellow investors, how value investing has and has not changed in the past four decades, why he avoids pharmaceutical stocks, what he's doing about his biggest recent mistake, and why he sees unrecognized value in Hartford Financial, Unum Group, Toyota and FedEx.

If you are a subscriber, log in to access the issue and bonus archive: